Sabra Health Care EVP sells 15,231 shares

Sabra Health Care REIT, Inc. Executive VP & CAO Jessica Flores reported an open-market sale of 15,231 shares of common stock on March 25, 2026 at a weighted average price of $19.86 per share, with individual trades ranging from $19.85 to $19.89.

Rhea-AI Filing Summary

Sabra Health Care REIT, Inc. Executive VP & CAO Jessica Flores reported an open-market sale of 15,231 shares of common stock on March 25, 2026 at a weighted average price of $19.86 per share, with individual trades ranging from $19.85 to $19.89.

After this transaction, she directly holds 71,709 shares, which include 25,527 stock units that will settle on a one-for-one basis in Sabra common stock.

Insider Trade Summary

Net Seller: 15,231 shares

Net Sell 1 txn

Insider FLORES JESSICA

Role Executive VP & CAO

Sold 15,231 shs ($302K)

Type	Security	Shares	Price	Value
Sale	Common Stock	15,231	$19.86	$302K

Holdings After Transaction: Common Stock — 71,709 shares (Direct)

Footnotes (2)

1. F1. The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $19.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. F2. Includes 25,527 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sabra Health Care REIT (SBRA) report for Jessica Flores?

Sabra Health Care REIT Executive VP & CAO Jessica Flores sold 15,231 shares of common stock in an open-market transaction. The weighted average sale price was $19.86 per share, based on multiple trades executed within a narrow price range.

At what prices did Jessica Flores sell Sabra Health Care REIT (SBRA) shares?

Jessica Flores sold her Sabra Health Care REIT common stock at a weighted average price of $19.86 per share. The individual transactions occurred at prices ranging from $19.85 to $19.89, according to the reported Form 4 footnote.

How many Sabra Health Care REIT (SBRA) shares does Jessica Flores hold after the sale?

Following the reported sale, Jessica Flores directly holds 71,709 shares of Sabra Health Care REIT common stock. This total includes 25,527 stock units that will settle on a one-for-one basis into Sabra common shares upon settlement.

What type of transaction did Jessica Flores execute in Sabra Health Care REIT (SBRA) stock?

Jessica Flores executed an open-market sale of Sabra Health Care REIT common stock. The transaction involved selling 15,231 shares, classified under transaction code “S,” which denotes a sale in the open market or a private transaction.

Do Jessica Flores’s remaining holdings in Sabra Health Care REIT (SBRA) include stock units?

Yes. Her remaining 71,709-share position includes 25,527 stock units. Upon settlement, each stock unit will be paid out in one share of Sabra Health Care REIT common stock, increasing her direct share count accordingly at that time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/26/2026 - 09:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FLORES JESSICA

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP & CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		S		15,231	D	$19.86(1)	71,709(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $19.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. Includes 25,527 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	03/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)